Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC00152
   Synonyms CYTOR, C2orf59, LINC00152, NCRNA00152, MGC4677
   Region GRCh38_2:87454781-87636740    Sequence
   Ensembl ENSG00000222041
   RefSeq NR_024204
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name gallbladder cancer
   ICD-0-3 C23.9  
   Methods qPCR, RNAi, Western blot, RIP, Luciferase reporter assay etc.
   Sample GBC tissues, cell lines (GBC-SD and H69)
   Expression Pattern up-regulated
   Function Description

LINC00152 is overexpressed in gallbladder cancer (GBC) tissue samples and cell lines.Functionally, LINC00152 dramatically promoted cell migration,invasion and epithelial-mesenchymal transition (EMT) progression in vitro. In vivo, LINC00152 overexpression significantly promoted tumour peritoneal spreading and metastasis. LINC00152 functions as a molecular sponge for miR-138, which directly suppresses the expression of HIF-1a.We revealed that miR-138 is a suppressor of GBC cell metastasis and EMT progression, and a similar phenomenon was observed in HIF-1a knockdown NOZ cells.

   Pubmed ID 28077595
   Year 2017
   Title Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1a via miR-138.
   External Links
   Links for  LINC00152 GenBank       HGNC       lncrnadb       Noncode
   Links for  gallbladder cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.